These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17167954)

  • 1. Results of cohort analysis by category of tuberculosis retreatment cases in Morocco from 1996 to 2003.
    Ottmani SE; Zignol M; Bencheikh N; Laâsri L; Chaouki N; Mahjour J
    Int J Tuberc Lung Dis; 2006 Dec; 10(12):1367-72. PubMed ID: 17167954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area.
    Schreiber YS; Herrera AF; Wilson D; Wallengren K; Draper R; Muller J; Dawood H; Doucette S; Cameron DW; Alvarez GG
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1274-80. PubMed ID: 19793433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of short course intermittent regimen on different categories of retreated patients with pulmonary tuberculosis].
    Wang X; Dai Y; Cao J
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Aug; 24(8):472-6. PubMed ID: 11718037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of tuberculosis retreatment in routine conditions in Cotonou, Benin.
    Gninafon M; Tawo L; Kassa F; Monteiro GP; Zellweger JP; Shang H; Lambregts K; Trébucq A
    Int J Tuberc Lung Dis; 2004 Oct; 8(10):1242-7. PubMed ID: 15527157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case series: initial outcome of persons with multidrug-resistant tuberculosis after treatment with the WHO standard retreatment regimen in Ho Chi Minh City, Vietnam.
    Lan NTN ; Lademarco MF; Binkin NJ; Tung LB; Quy HT; Cĵ NV
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):575-8. PubMed ID: 11409587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low failure rate in standardised retreatment of tuberculosis in Nicaragua: patient category, drug resistance and survival of 'chronic' patients.
    Heldal E; Arnadottir T; Cruz JR; Tardencilla A; Chacon L
    Int J Tuberc Lung Dis; 2001 Feb; 5(2):129-36. PubMed ID: 11258506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Source of retreatment cases under the revised national TB control programme in Rajasthan, India, 2003.
    Sisodia RS; Wares DF; Sahu S; Chauhan LS; Zignol M
    Int J Tuberc Lung Dis; 2006 Dec; 10(12):1373-9. PubMed ID: 17167955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcome of relapse and defaulter pulmonary tuberculosis patients.
    Sevim T; Ataç G; Güngör G; Törün I; Aksoy E; Gemci ; Tahaoglu K
    Int J Tuberc Lung Dis; 2002 Apr; 6(4):320-5. PubMed ID: 11936741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DOTS strategy for treatment of paediatric pulmonary tuberculosis in South Delhi, India.
    Sharma S; Sarin R; Khalid UK; Singla N; Sharma PP; Behera D
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):74-80. PubMed ID: 18173881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of different subgroups of smear-positive retreatment patients under RNTCP in rural West Bengal, India.
    Mukherjee A; Sarkar A; Saha I; Biswas B; Bhattacharyya PS
    Rural Remote Health; 2009; 9(1):926. PubMed ID: 19260766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retreatment management strategies when first-line tuberculosis therapy fails.
    Saravia JC; Appleton SC; Rich ML; Sarria tM; Bayona J; Becerra MC
    Int J Tuberc Lung Dis; 2005 Apr; 9(4):421-9. PubMed ID: 15830748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and outcome of tuberculosis patients who fail treatment under routine programme conditions in Malawi.
    Harries AD; Nyirenda TE; Kemp JR; Squire BS; Godfrey-Faussett P; Salaniponi FM
    Int J Tuberc Lung Dis; 2003 Nov; 7(11):1040-4. PubMed ID: 14598962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative anti-tuberculosis regimen including ofloxacin for the treatment of patients with hepatic injury.
    Szklo A; Mello FC; Guerra RL; Dorman SE; Muzy-de-Souza GR; Conde MB
    Int J Tuberc Lung Dis; 2007 Jul; 11(7):775-80. PubMed ID: 17609053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Category II anti-tuberculosis treatment in Indian children.
    Mukherjee A; Khandelwal D; Singla M; Lodha R; Kabra SK
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1153-7. PubMed ID: 26459525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB.
    Rich ML; Socci AR; Mitnick CD; Nardell EA; Becerra MC; Bonilla C; Bayona J; Seung KJ; Furin J; Farmer PE; Mukherjee JS
    Int J Tuberc Lung Dis; 2006 Mar; 10(3):290-6. PubMed ID: 16562709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent tuberculosis: definitions and treatment regimens.
    Harries AD; Hargreaves NJ; Kwanjana JH; Salaniponi FM
    Int J Tuberc Lung Dis; 1999 Oct; 3(10):851-4. PubMed ID: 10524580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
    Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.